Inside the Fight for Chronic Illness Survival
The podcast that goes where pharmaceutical-funded platforms cannot. Real cases. Real federal records. Real accountability. Hosted by Jeff Parke — three-time kidney transplant recipient, clinical research professional, and the person who mapped the failures before building the tools to fight them.
Subscribe on Podbean and be the first to know when new episodes drop bi-monthly. No pharmaceutical sponsorship. Ever.
Also available on Spotify · Apple Podcasts · iHeart · Amazon Music once live
The $600 billion in unpaid annual caregiving labor that sustains the American healthcare system. Who benefits. Who pays the price. What federal legislation has failed to do about it for forty years — and what we are demanding instead.
How pharmaceutical companies fund the organizations claiming to represent patients — and how that funding shapes every policy position, every public statement, and every legislative priority those organizations promote. Named organizations. Documented funding sources. Public records.
Allocation failures. OPO performance gaps. Organs lost in transit. Federal investigations that produce reports and no consequences. The structural dysfunction inside the national organ transplant system and the institutional resistance to every meaningful reform attempt.
Short-form investigations, care partner briefings, and accountability reports — all produced without pharmaceutical sponsorship.
Each episode is built around documented evidence — federal reports, GAO findings, OIG investigations, court records, and the lived testimony of care partners navigating the system firsthand.
Depression rates three times national average. Zero institutional response. The clinical evidence and the platform tools that close the gap.
Mental Health · Season 1$600 billion in unpaid labor. The legislative failure. What we are demanding instead.
Legislative · Season 1Named organizations. Documented funding. The conflict of interest that shapes every major policy position in patient advocacy.
Investigative · Coming SoonOrgans lost. OPOs underperforming. Federal investigations with no consequences.
Federal Oversight · Coming SoonTwo corporations. 80% market share. The reimbursement structures they helped design.
Industry · CMS · Coming SoonAI-driven denial tools. No physician review. What the law requires vs. what insurers do.
Insurance · ERISA · Coming SoonWhy every care partner compensation bill stalls. Who opposes them. What needs to change.
Congress · Policy · Coming SoonDocumented disparities in waitlist placement and organ offer rates. The federal data. The human cost.
Health Equity · OPTNDangerous treatment gaps. The legal rights most patients do not know they have.
Patient Rights · ESRD Networks
Jeff Parke is not an observer of the chronic illness system. He is a three-time kidney transplant recipient who spent decades as a clinical research professional — inside the machine that was failing his family, learning exactly how it produces knowledge, protects itself, and decides what patients and care partners are and are not allowed to know.
Cold Truth is the product of that combination. Patient experience. Systems expertise. Zero pharmaceutical conflicts. Every episode is built on documented federal evidence and the lived reality of people who needed tools the system was never going to provide.
Jeff is also the author of and the Executive Director of Cold Ischemia Foundation — America's only independent care partner advocacy platform for chronic illness.
Care partners, clinicians, policy advocates, journalists, and anyone with direct experience of the structural failures Cold Truth covers. Named or anonymous — your choice entirely.
Direct to Jeff Parke · No third-party routing · No corporate filter
Jeff Parke will review your submission personally and reach out directly. Thank you for being willing to put your voice on the record.
Editorial Independence — Permanent & Non-Negotiable. Cold Truth accepts no advertising, sponsorship, or funding from pharmaceutical companies, dialysis corporations, medical device manufacturers, hospital systems, or any entity with a financial interest in the policies this podcast scrutinizes. Every episode is produced entirely free from commercial influence. We answer to one constituency: care partners.